RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE)
EUR 14.8
(-2.63%)
EUR 14.8
(-2.63%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 198.49 Million EUR | -86.37% |
| 2022 | 999.52 Million EUR | 2.87% |
| 2021 | 971.61 Million EUR | 3.61% |
| 2020 | 937.72 Million EUR | 4.66% |
| 2019 | 895.97 Million EUR | 4.13% |
| 2018 | 860.46 Million EUR | -0.35% |
| 2017 | 863.52 Million EUR | 1.97% |
| 2016 | 846.8 Million EUR | 7.69% |
| 2015 | 786.35 Million EUR | -27.55% |
| 2014 | 1.08 Billion EUR | -51.16% |
| 2013 | 2.22 Billion EUR | 5.24% |
| 2012 | 2.11 Billion EUR | 8.26% |
| 2011 | 1.95 Billion EUR | 3.01% |
| 2010 | 1.89 Billion EUR | 9.77% |
| 2009 | 1.72 Billion EUR | 8.46% |
| 2008 | 1.59 Billion EUR | -36.92% |
| 2007 | 2.52 Billion EUR | 3.97% |
| 2006 | 2.42 Billion EUR | 37.83% |
| 2005 | 1.75 Billion EUR | 35.63% |
| 2004 | 1.29 Billion EUR | 78.71% |
| 2003 | 725.84 Million EUR | 8.69% |
| 2002 | 667.8 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -14.29 Million EUR | 32.37% |
| 2024 Q1 | -21.12 Million EUR | 0.32% |
| 2023 Q4 | -21.19 Million EUR | -108.84% |
| 2023 Q1 | 241.56 Million EUR | -7.01% |
| 2023 Q3 | 239.76 Million EUR | -3.91% |
| 2023 FY | 136.24 Million EUR | -86.37% |
| 2023 Q2 | 249.52 Million EUR | 3.3% |
| 2022 Q1 | 239.79 Million EUR | -7.13% |
| 2022 Q2 | 257.42 Million EUR | 7.35% |
| 2022 FY | 999.52 Million EUR | 2.87% |
| 2022 Q3 | 242.54 Million EUR | -5.78% |
| 2022 Q4 | 259.76 Million EUR | 7.1% |
| 2021 Q2 | 242.59 Million EUR | 3.91% |
| 2021 Q3 | 237.34 Million EUR | -2.16% |
| 2021 Q4 | 258.2 Million EUR | 8.79% |
| 2021 Q1 | 233.47 Million EUR | -1.06% |
| 2021 FY | 971.61 Million EUR | 3.61% |
| 2020 FY | 937.72 Million EUR | 4.66% |
| 2020 Q3 | 237.75 Million EUR | 0.37% |
| 2020 Q4 | 235.97 Million EUR | -0.75% |
| 2020 Q2 | 236.87 Million EUR | 4.29% |
| 2020 Q1 | 227.12 Million EUR | 0.81% |
| 2019 Q1 | 228.18 Million EUR | 8.13% |
| 2019 FY | 895.97 Million EUR | 4.13% |
| 2019 Q2 | 220.09 Million EUR | -3.54% |
| 2019 Q3 | 222.38 Million EUR | 1.04% |
| 2019 Q4 | 225.3 Million EUR | 1.31% |
| 2018 Q2 | 217.56 Million EUR | -0.58% |
| 2018 Q3 | 213.04 Million EUR | -2.08% |
| 2018 Q4 | 211.02 Million EUR | -0.95% |
| 2018 Q1 | 218.83 Million EUR | 0.93% |
| 2018 FY | 860.46 Million EUR | -0.35% |
| 2017 Q3 | 217.44 Million EUR | 2.31% |
| 2017 FY | 863.52 Million EUR | 1.97% |
| 2017 Q4 | 216.82 Million EUR | -0.29% |
| 2017 Q2 | 212.52 Million EUR | -1.94% |
| 2017 Q1 | 216.73 Million EUR | 2.56% |
| 2016 Q1 | 210.87 Million EUR | 9.16% |
| 2016 Q2 | 214.22 Million EUR | 1.59% |
| 2016 Q3 | 210.37 Million EUR | -1.79% |
| 2016 Q4 | 211.32 Million EUR | 0.45% |
| 2016 FY | 846.8 Million EUR | 7.69% |
| 2015 Q2 | 201.26 Million EUR | 2.6% |
| 2015 Q1 | 196.17 Million EUR | 3.66% |
| 2015 FY | 786.35 Million EUR | -27.55% |
| 2015 Q4 | 193.18 Million EUR | -1.3% |
| 2015 Q3 | 195.73 Million EUR | -2.75% |
| 2014 Q4 | 189.23 Million EUR | -4.54% |
| 2014 Q2 | 234.56 Million EUR | -49.38% |
| 2014 FY | 1.08 Billion EUR | -51.16% |
| 2014 Q3 | 198.23 Million EUR | -15.49% |
| 2014 Q1 | 463.37 Million EUR | -16.69% |
| 2013 Q3 | 551.78 Million EUR | -0.99% |
| 2013 Q4 | 556.18 Million EUR | 0.8% |
| 2013 FY | 2.22 Billion EUR | 5.24% |
| 2013 Q2 | 557.27 Million EUR | 0.06% |
| 2013 Q1 | 556.92 Million EUR | 1.55% |
| 2012 Q3 | 537.26 Million EUR | 3.01% |
| 2012 Q2 | 521.58 Million EUR | 3.43% |
| 2012 Q1 | 504.27 Million EUR | 1.78% |
| 2012 FY | 2.11 Billion EUR | 8.26% |
| 2012 Q4 | 548.43 Million EUR | 2.08% |
| 2011 Q2 | 485.55 Million EUR | 1.25% |
| 2011 Q1 | 479.58 Million EUR | 0.85% |
| 2011 Q3 | 489.92 Million EUR | 0.9% |
| 2011 Q4 | 495.45 Million EUR | 1.13% |
| 2011 FY | 1.95 Billion EUR | 3.01% |
| 2010 Q1 | 463.04 Million EUR | 5.3% |
| 2010 FY | 1.89 Billion EUR | 9.77% |
| 2010 Q4 | 475.54 Million EUR | -0.35% |
| 2010 Q3 | 477.2 Million EUR | -0.1% |
| 2010 Q2 | 477.69 Million EUR | 3.16% |
| 2009 FY | 1.72 Billion EUR | 8.46% |
| 2009 Q4 | 439.75 Million EUR | 1.32% |
| 2009 Q3 | 434.03 Million EUR | -0.35% |
| 2009 Q2 | 435.56 Million EUR | 4.82% |
| 2009 Q1 | 415.53 Million EUR | 0.0% |
| 2008 FY | 1.59 Billion EUR | -36.92% |
| 2007 FY | 2.52 Billion EUR | 3.97% |
| 2006 FY | 2.42 Billion EUR | 37.83% |
| 2005 FY | 1.75 Billion EUR | 35.63% |
| 2004 FY | 1.29 Billion EUR | 78.71% |
| 2003 FY | 725.84 Million EUR | 8.69% |
| 2002 FY | 667.8 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 4.92 Billion EUR | 95.969% |
| Fresenius SE & Co. KGaA | 5.05 Billion EUR | 96.076% |
| LIMES Schlosskliniken AG | 13.58 Million EUR | -1361.073% |
| M1 Kliniken AG | 26.66 Million EUR | -644.445% |
| Maternus-Kliniken Aktiengesellschaft | 11.9 Million EUR | -1567.703% |
| MEDICLIN Aktiengesellschaft | 144.11 Million EUR | -37.728% |
| VITA 34 AG | 28.24 Million EUR | -602.769% |